OLR1 and head and neck squamous cell carcinoma: To evaluate the contribution of blood circulating MDSCs to the clinical outcome of (R/M) HNSCC patients, the levels of LOX-1+PMN-MDSCs and M-MDSCs were freshly analyzed at baseline (T0).